The role of C-reactive protein in modern obstetric and gynecological practice

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 4, 2006, Pages 394-401

  Azizia, Mohammad ^a   Irvine, Laurie M ^a   Coker, Marcellina ^a   Sanusi, Fatai ^a  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Gynecology; Obstetrics

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ABDOMINAL DISEASE; BODY MASS; CHORIOAMNIONITIS; CLINICAL PRACTICE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GYNECOLOGIC DISEASE; HORMONE SUBSTITUTION; HUMAN; INFECTION; INFLAMMATION; OBSTETRIC CARE; PELVIC INFLAMMATORY DISEASE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; BLOOD; DIFFERENTIAL DIAGNOSIS; GYNECOLOGY; METHODOLOGY; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATION; UROGENITAL TRACT DISEASE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEMALE UROGENITAL DISEASES; GYNECOLOGY; HUMANS; INFLAMMATION; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33646381926     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500432614     Document Type: Review

References (84)

1. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus. J Exp Med. 1930;52:561-71.
2. Abernathy TJ, Avery OT. The occurrence during acute infection of a protein not normally present in the blood. I. Distribution of the reactive protein in patients' sera and the effects of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med. 1941;73:173.
3. MacLeod CM, Avery OT. The occurrence during acute infections of a protein not normally present in blood. II. Isolation and properties of the C-reactive protein. J Exp Med. 1941;73:183.
4. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med. 1992;37:313-36.
5. Gambino R. C-reactive protein - undervalued, underutilized. Clin Chem. 1997;43(11):2017-8.
6. Gotschlich EC. C-reactive protein. A historical overview. Ann N Y Acad Sci. 1989;557:9-18.
7. Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology. 1991;183:133-45.
8. Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1:653-7.
9. Palosuo T, Husman T, Koistinen J, Aho K. C-reactive protein in population samples. Acta Med Scand. 1986;220:175-9.
10. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16:735-47.
11. International Committee for Standardization in Haematology. Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 1988; 41: 1203-12.
12. Deodar SD. C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med. 1989;56:126-30.
13. Stuart J, Whicher JT. Tests for detecting and monitoring the acute phase response. Arch Dis Child. 1988;63:115-7.
14. Okamura JM, Miyagi JM, Terada K, Hokama Y. Potential clinical applications of C-reactive protein. J Clin Lab Anal. 1990;4:231-5.
15. Sanchez A, Mirabel JL, Barrenechea E, Eugui J, Puelles A, Castaneda A. Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 Analyzer. Clin Lab. 2002;48(5-6):313-7.
16. Van Lente F, Marchand A, Galen RS. Evaluation of the nephelometric assay of CRP using the Beckman ICS. Clin Chem. 1981;27:1075.
17. Jupe D. The acute phase response and laboratory testing. Aust Fam Phys. 1996;25:324-9.
18. Harmoinen A, Hallstrom O, Gronroos P. Rapid quantitative determination of C-reactive protein using laser nephelometer. Scand J Clin Lab Invest. 1980;40:293.
19. Loukovaara MJ, Alfthan HV, Kurki MT, Hiilesmaa VK, Andersson SH. Serum highly sensitive C-reactive protein in preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):26-8.
20. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23:118-24.
21. Gibbs RS, Blanco JD. Premature rupture of the membranes. Obstet Gynecol. 1982;60(6):671-9.
22. Kurki T, Teramo K, Ylikorkala O, Paavonen J. C-reactive protein in preterm premature rupture of the membranes. Arch Gynecol Obstet. 1990;247(1):31-7.
23. Nowak M, Oszukowski P, Szpakowski M, Malinowski A, Maciolek-Blewniewska G. Intrauterine infections. I. The role of C-reactive protein, white blood cell count and erythrocyte sedimentation rate in pregnant women in the detection of intrauterine infection after preliminary rupture of membranes]. Ginekol Pol. 1998;69(8):615-22.
24. Evans MI, Hajj SN, Devoe LD, Angerman NS, Moawad AH. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes. Am J Obstet Gynecol. 1980;138(6):648-52.
25. Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol. 1985;151(4):541-4.
26. Awara AM, Marei SK, Elghorab NM, Elnewahy MA, Aboulenin AA. Predictive value of C-reactive protein in serum of maternal and cord blood in cases with premature rupture of membranes. Egypt Med J. 1992;9(2):31-7.
27. Fisk NM, Fysh J, Child AG, Gatenby PA, Jeffery H, Bradfield AH. Is C-reactive protein really useful in preterm premature rupture of the membranes? Br J Obstet Gynaecol. 1987;94(12):1159-64.
28. Saini S, Goel N, Sharma M, Arora B, Garg N. C-reactive proteins as an indicator of sub-clinical infection in cases of premature rupture of membranes. Indian J Pathol Microbiol. 2003;46(3):515-6.
29. Sereepapong W, Limpongsanurak S, Triratanachat S, Wannakrairot P, Charuruks N, Krailadsiri P. The role of maternal serum C-reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes. J Med Assoc Thai. 2001;84(Suppl 1):S360-6.
30. Romem Y, Artal R. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol. 1984;150(5 Pt 1):546-50.
31. Hawrylyshyn P, Bernstein P, Milligan JE, Soldin S, Pollard A, Papsin FR. Premature rupture of membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol. 1983;147(3):240-6.
32. Di Naro E, Ghezzi F, Raio L, Romano F, Mueller MD, McDougall J, Cicinelli E. C-reactive protein in vaginal fluid of patients with preterm premature rupture of membranes. Acta Obstet Gynecol Scand. 2003;82(12):1072-9.
33. Hirsch W, Koppitz D, Morack G, Gerhardt C. C-reactive protein in the maternal serum and risk of fetal infection in premature rupture of the fetal membranes and threatened premature labor]. Zentralbl Gynakol. 1989;111(21):1411-6.
34. de Souza JJ, Perlmann T, Herman AA, Ransome OJ, Kantor RW. C-reactive protein as a predictor of fetal and maternal infective morbidity and fetal mortality. S Afr Med J. 1987;71(11):690-2.
35. Rush RW, Kierse MJNC, Howat P. Contribution of preterm delivery to perinatal mortality. BMJ. 1976;2:965-8.
36. Lamont RF. The role of infection in preterm labour and birth. Hosp Med. 2003;64(11):644-7.
37. Friese K. The role of infection in preterm labour. BJOG. 2003;110(Suppl 20):52-4.
38. Radnai M, Gorzo II, Nagy E, Urban E, Novak T, Pal A. A possible association between preterm birth and early periodontitis. J Clin Periodontol. 2004;31(9):736-41.
39. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003;189(1):139-47.
40. Cammu H, Goossens A, Derde MP, Temmerman M, Foulon W, Amy JJ. C-reactive protein in preterm labour: association with outcome of tocolysis and placental histology. Br J Obstet Gynaecol. 1989;96(3):314-9.
41. Mazor M, Kassis A, Horowitz S, Wiznitzer A, Kuperman O, Meril C, et al. Relationship between C-reactive protein levels and intraamniotic infection in women with preterm labor. J Reprod Med. 1993;38(10):799-803.
42. Watts DH, Krohn MA, Hillier SL, Wener MH, Kiviat NB, Eschenbach DA. Characteristics of women in preterm labor associated with elevated C-reactive protein levels. Obstet Gynecol. 1993;82(4 Pt 1):509.
43. Mazor M, Zitzer P, Chaim W, Maymon E, Kuperman O. C-reactive protein as a marker of infection in women with preterm delivery]. Harefuah. 1993;124(3):132-7, 183-4.
44. Potkul RK, Moawad AH, Ponto KL. The association of subclinical infection with preterm labor: the role of C-reactive protein. Am J Obstet Gynecol. 1985;153(6):642-5.
45. Winkler M, Gellings R, Putz I, Funk A, Goetz M. Puerperium after threatened premature labor - positive effects of infection screening by determination of CRP in pregnancy]. Zentralbl Gynakol. 1994;116(10):555-60.
46. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand. 2002;81(5):424-9.
47. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol. 2002;186(2):268-73.
48. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 20032: CD001058.
49. Bollen B, Padwick M. Delayed delivery of second twin after chorioamnionitis and abortion of first twin at 21 weeks gestation. Eur J Obstet Gynecol Reprod Biol. 2000;93(1):109-10.
50. Soper DE. Diagnosis and laparoscopic grading of acute salpingitis. Am J Obstet Gynecol. 1991;164:1370-6.
51. Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol. 1993;169(5):1143-9.
52. Lehtinen M, Laine S, Heinonen PK, Teisala K, Miettinen A, Aine R, et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol. 1986;154:158-9.
53. Reljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet. 1998;60(2):143-50.
54. Schmidt-Rhode P, Schulz KD, Sturm G, Prinz H. C-reactive protein is a marker for the diagnosis of adnexitis. Int J Gynaecol Obstet. 1990;32(2):133-9.
55. Teisala K, Heinonen PK. C-reactive protein in assessing antimicrobial treatment of acute pelvic inflammatory disease. J Reprod Med. 1990;35(10):955-8.
56. Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand. 1975;64:201-8.
57. Hellerstein S, Duggan E, Welchert E, Mansour F. Serum C-reactive protein and the site of urinary tract infections. J Pediatr. 1982;100:21-5.
58. Sandberg T, Lidin-Janson G, Eden CS. Host response in women with symptomatic urinary tract infection. Scand J Infect Dis. 1989;21(1):67-73.
59. Chase HP, Cooper S, Osberg I, Stene LC, Barriga K, Norris J, et al. Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes. 2004;53(10):2569-73.
60. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693-700.
61. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 2003;26(3):819-24.
62. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18(5):377-84.
63. Sitruk-Ware RL. Hormone therapy and the cardiovascular system: the critical role of progestins. Climacteric. 2003; 6(Suppl 3):21-8.
64. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M et al; The HIFMECH Study Group. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004;53(7):852-7.
65. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109(21 Suppl 1):II2-10.
66. Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obstet Gynecol. 2002;186(5):969-77.
67. Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord. 2004;28(8):998-1003.
68. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80-6.
69. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499-506.
70. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod. 2004;19(4):1025-30.
71. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004;17(2):154-60.
72. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003; 59(1):29-37.
73. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol. 2001;98(5 Pt 1):757-62.
74. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet. 2001;75(3):243-9.
75. Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy. 2003;22(2):129-41.
76. Hallan S, Asberg A. The accuracy of C-reactive protein in diagnosing acute appendicitis - a meta-analysis. Scand J Clin Lab Invest. 1997;57:373-80.
77. Erkasap S, Ates E, Ustuner Z, Sahin A, Yilmaz S, Yasar B, et al. Diagnostic value of interleukin-6 and C-reactive protein in acute appendicitis. Swiss Surg. 2000;6(4):169-72.
78. Juvonen T, Kiviniemi H, Niemela O, Kairaluoma MI. Diagnostic accuracy of ultrasonography and C-reactive protein concentration in acute cholecystitis: a prospective clinical study. Eur J Surg. 1992;158:365-9.
79. Sternby B, O'Brien JF, Zinsmeister AR, DiMagno EP. What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study. Mayo Clin Proc. 1996;71:1138-44.
80. Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol. 1992;44(2):147-54.
81. Palmer A, Carlin JB, Freihorst J, Gatchalian S, Muhe L, Mulholland K et al; WHO Young Infant Study Group. The use of CRP for diagnosing infections in young infants <3 months of age in developing countries. Ann Trop Paediatr 2004; 24(3): 205-12.
82. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24(10):1052-6.
83. Borrelli PT, Butler SA, Docherty SM, Staite EM, Borrelli AL, Iles RK. Human chorionic gonadotropin isoforms in the diagnosis of ectopic pregnancy. Clin Chem. 2003;49(12):2045-9.
84. Mora J, Gascon N, Tabernero JM, Germa JR, Gonzalez F. Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases. Eur J Cancer. 1995;31A(13-14):2239-42.